Physician profile
Gregory Nicholson
NPI 1477532141
$6,715,019.45
in general payments reported to CMS, 2019-2025
15 companies · $1.7M in 2025
The $1.7M reported for 2025 was more than what 99% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425K · 2020: $433K · 2021: $617K · 2022: $878K · 2023: $1.2M · 2024: $1.4M · 2025: $1.7M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4.2M · Consulting Fee: $103K · Travel and Lodging: $14K · Food and Beverage: $2,775 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,240,369.76 |
| Consulting Fee | $103,000.00 |
| Travel and Lodging | $13,965.25 |
| Food and Beverage | $2,774.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,692,408.99 | 2020-2025 | Aequalis Perform, Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Glenoid |
| Wright Medical Technology, INC. | $808,891.84 | 2019-2020 | |
| Anika Therapeutics, INC. | $139,131.34 | 2021-2024 | Ovomotion, Revomotion, Revomotion |
| Arthrosurface Incorporated | $69,682.59 | 2019-2025 | Ovomotion, Revomotion, Hemicapovo |
| Kci USA, INC. | $2,178.66 | 2021 | |
| Azurmeds, INC. | $1,905.40 | 2021-2022 | |
| Exactech, INC. | $158.08 | 2022 | |
| Responsive Arthroscopy INC | $151.51 | 2019 | |
| Smith+Nephew, INC. | $148.99 | 2019 | |
| Encore Medical, Lp | $121.37 | 2019 | |
| Medacta USA, INC. | $98.35 | 2021 | |
| Zimmer Biomet Holdings, INC. | $82.84 | 2019-2025 | |
| Vertex Pharmaceuticals Incorporated | $25.80 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $21.31 | 2019 | |
| Heraeus Medical, LLC. | $12.38 | 2023 | Palacos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.